India virus covid-19 outbreak patient India

Gilead says in talks with India for making Covid-19 drug remdesivir

Reading now: 363
www.livemint.com

Gilead Sciences Inc said on Tuesday it was in discussions with chemical and drug manufacturers to produce its experimental COVID-19 drug remdesivir for Europe, Asia and the developing world through at least 2022.

The drugmaker did not disclose details about the companies. With several countries across the globe reeling from the virus outbreak, interest in remdesivir has been high as there are currently no approved treatments or vaccines for COVID-19, the respiratory illness caused by the new coronavirus.

Gilead last week received the U.S. Food and Drug Administration's emergency use authorization for using remdesivir as a treatment against COVID-19, after the drugmaker provided data showing the drug had helped COVID-19 patients.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA